This week, the FDA opened applications for its Expedited IND Pilot, quality experts presented at the PDA/FDA Joint Regulatory Conference, and Hovione expanded its spray drying capacity.
|Articles|April 23, 2010
New weldable pump tube
PureWeld XL from Watson-Marlow, a new weldable and ADCF (animal-derived contents free) tube for use in bio-pharmaceutical processes, provides users with secure joins that allow for a connector-free fluid path. PureWeld demonstrates very low internal spallation and gives long tube life in peristaltic pump applications.
Advertisement
New PureWeld XL is a thermoplastic elastomer tubing designed to deliver purity and performance in single-use bioprocessing applications. PureWeld XL can be securely welded, allowing complete, connector-free fluid paths to be assembled in minutes.
- Sterile,weldable and heat sealable
- Animal derived content free
- Provides very stable flow rates with the lowest spallation
- FDA CFR 177.1810, USP Class VI and European Pharmacopoeia certification
A high-quality peristaltic pump tubing, PureWeld XL gives users improved pumping performance over many alternative weldable tube products. PureWeld XL is manufactured in a Class J10,000 cleanroom by Watson-Marlow, the world’s leading peristaltic pump manufacturer. Validation and extractables profiles are available.
Advertisement
Related to this article
Christy Owings, Thermo Fisher, explains clinical trial supply chain risks in Latin America, importer-of-record strategy, AI, and eCOA delays.
PharmTech AI Pulse Check debuts: pharma experts tackle GxP 'slop,' multi-agent validation risk, OCR document mining, personalized mRNA cancer therapy.
Andrea K. Kerrigan, FDA, outlines how validation, data integrity, and QRM determine whether digital tools and AI strengthen or undermine CGMP compliance.
PharmTech spoke with Tara Dougal, event director for pharma at Informa Markets, about trends impacting the pharmaceutical industry and how CPHI Milan is addressing these areas this year.
Andrew Parker, PhD, executive drug development consultant, Quotient Sciences, explains how AI is integrated into pharmaceutical development.
PDA/FDA 2026 session maps the GMP audit lifecycle, root cause to CAPA closure, plus a local vs. above-site decision framework and two case studies.
The recently opened NJ spray drying facility doubles capacity for amorphous solid dispersions, addressing solubility limits in roughly 70% of small-molecule pipelines.
Advertisement
Advertisement